BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38368725)

  • 1. Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy.
    Zanchi C; Locatelli M; Cerullo D; Aumiller V; Corna D; Rottoli D; Schubert S; Noris M; Tomasoni S; Remuzzi G; Zoja C; Benigni A
    Mol Immunol; 2024 Apr; 168():10-16. PubMed ID: 38368725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation.
    Zanchi C; Locatelli M; Corna D; Cerullo D; Fishilevich E; Desai D; Rottoli D; Donadelli R; Noris M; Zoja C; Remuzzi G; Benigni A
    Mol Immunol; 2023 Sep; 161():25-32. PubMed ID: 37481826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy.
    Zanchi C; Locatelli M; Cerullo D; Aumiller V; Corna D; Rottoli D; Eisermann M; Donadelli R; Mousavi M; Noris M; Remuzzi G; Benigni A; Zoja C
    J Immunol; 2022 Apr; 208(7):1772-1781. PubMed ID: 35277417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof of concept of a new plasma complement Factor H from waste plasma fraction.
    Mori F; Pascali G; Berra S; Lazzarotti A; Panetta D; Rocchiccioli S; Ceccherini E; Norelli F; Morlando A; Donadelli R; Clivio A; Farina C; Noris M; Salvadori PA; Remuzzi G
    Front Immunol; 2024; 15():1334151. PubMed ID: 38919628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Targeted Complement Inhibition in Experimental C3 Glomerulopathy.
    Ruseva MM; Peng T; Lasaro MA; Bouchard K; Liu-Chen S; Sun F; Yu ZX; Marozsan A; Wang Y; Pickering MC
    J Am Soc Nephrol; 2016 Feb; 27(2):405-16. PubMed ID: 26047789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C3(H2O) prevents rescue of complement-mediated C3 glomerulopathy in Cfh-/- Cfd-/- mice.
    Zhang Y; Keenan A; Dai DF; May KS; Anderson EE; Lindorfer MA; Henrich JB; Pitcher GR; Taylor RP; Smith RJ
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homodimeric Minimal Factor H:
    Kamala O; Malik TH; Hallam TM; Cox TE; Yang Y; Vyas F; Luli S; Connelly C; Gibson B; Smith-Jackson K; Denton H; Pappworth IY; Huang L; Kavanagh D; Pickering MC; Marchbank KJ
    Front Immunol; 2021; 12():752916. PubMed ID: 34956184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial Complement Factor H Deficiency Associates with C3 Glomerulopathy and Thrombotic Microangiopathy.
    Vernon KA; Ruseva MM; Cook HT; Botto M; Malik TH; Pickering MC
    J Am Soc Nephrol; 2016 May; 27(5):1334-42. PubMed ID: 26374608
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Piras R; Breno M; Valoti E; Alberti M; Iatropoulos P; Mele C; Bresin E; Donadelli R; Cuccarolo P; Smith RJH; Benigni A; Remuzzi G; Noris M
    Front Genet; 2021; 12():670727. PubMed ID: 34211499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Engineered Complement Factor H Construct for Treatment of C3 Glomerulopathy.
    Yang Y; Denton H; Davies OR; Smith-Jackson K; Kerr H; Herbert AP; Barlow PN; Pickering MC; Marchbank KJ
    J Am Soc Nephrol; 2018 Jun; 29(6):1649-1661. PubMed ID: 29588430
    [No Abstract]   [Full Text] [Related]  

  • 11. Humanized C3 Mouse: A Novel Accelerated Model of C3 Glomerulopathy.
    Devalaraja-Narashimha K; Meagher K; Luo Y; Huang C; Kaplan T; Muthuswamy A; Halasz G; Casanova S; O'Brien J; Peyser Boiarsky R; McWhirter J; Gartner H; Bai Y; MacDonnell S; Liu C; Hu Y; Latuszek A; Wei Y; Prasad S; Huang T; Yancopoulos G; Murphy A; Olson W; Zambrowicz B; Macdonald L; Morton LG
    J Am Soc Nephrol; 2021 Jan; 32(1):99-114. PubMed ID: 33288630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of Fatal C3 Glomerulopathy by Recombinant Complement Receptor of the Ig Superfamily.
    Wang X; Van Lookeren Campagne M; Katschke KJ; Gullipalli D; Miwa T; Ueda Y; Wang Y; Palmer M; Xing G; Song WC
    J Am Soc Nephrol; 2018 Aug; 29(8):2053-2059. PubMed ID: 29895552
    [No Abstract]   [Full Text] [Related]  

  • 13. Factor H-Related Protein 1 Drives Disease Susceptibility and Prognosis in C3 Glomerulopathy.
    Márquez-Tirado B; Gutiérrez-Tenorio J; Tortajada A; Lucientes Continente L; Caravaca-Fontán F; Malik TH; Roldán Montero R; Elías S; Saiz Gonzalez A; Fernández-Juarez G; Sánchez-Corral P; Pickering MC; Praga M; Rodríguez de Córdoba S; Goicoechea de Jorge E
    J Am Soc Nephrol; 2022 Jun; 33(6):1137-1153. PubMed ID: 35545301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH; Gitterman DP; Lavin DP; Lomax-Browne HJ; Hiemeyer EC; Moran LB; Boroviak K; Cook HT; Gilmore AC; Mandwie M; Ahmad A; Alexander IE; Logan GJ; Marchbank KJ; Bradley A; Pickering MC
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33753502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An extended mini-complement factor H molecule ameliorates experimental C3 glomerulopathy.
    Nichols EM; Barbour TD; Pappworth IY; Wong EK; Palmer JM; Sheerin NS; Pickering MC; Marchbank KJ
    Kidney Int; 2015 Dec; 88(6):1314-1322. PubMed ID: 26221753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amnion epithelial cells are an effective source of factor H and prevent kidney complement deposition in factor H-deficient mice.
    Casiraghi F; Ordonez PYR; Azzollini N; Todeschini M; Rottoli D; Donadelli R; Gramignoli R; Benigni A; Noris M; Remuzzi G
    Stem Cell Res Ther; 2021 Jun; 12(1):332. PubMed ID: 34112227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy.
    Chauvet S; Roumenina LT; Aucouturier P; Marinozzi MC; Dragon-Durey MA; Karras A; Delmas Y; Le Quintrec M; Guerrot D; Jourde-Chiche N; Ribes D; Ronco P; Bridoux F; Fremeaux-Bacchi V
    Front Immunol; 2018; 9():2260. PubMed ID: 30333829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency.
    Ruseva MM; Vernon KA; Lesher AM; Schwaeble WJ; Ali YM; Botto M; Cook T; Song W; Stover CM; Pickering MC
    J Am Soc Nephrol; 2013 Jan; 24(1):43-52. PubMed ID: 23184055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defining the complement biomarker profile of C3 glomerulopathy.
    Zhang Y; Nester CM; Martin B; Skjoedt MO; Meyer NC; Shao D; Borsa N; Palarasah Y; Smith RJ
    Clin J Am Soc Nephrol; 2014 Nov; 9(11):1876-82. PubMed ID: 25341722
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.